Skip to main content

An official website of the State of Maryland.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Processor Guidance Only & FAQs

Updated:

The following guidance is provided by the Maryland Cannabis Administration (MCA) to assist cannabis licensees comply with State laws and regulations governing the cannabis industry. This document is not legal advice. It is meant to highlight operational changes for licensed processors. Please consult an attorney if you have any questions regarding the legal requirements that apply. 

Highlighted updates 

Recent updates to regulations make certain changes for processor licensees, with an anticipated effective date of April 14, 2025, including but not limited to the following: 

  • If a licensee finds evidence of theft or diversion, they must report the finding to MCA within 1 business day but are no longer required to notify local law enforcement.
  • Establishes a new process by which processors may request MCA’s approval of new/novel cannabis product types not currently authorized in Maryland but lawfully produced in another jurisdiction. MCA intends to fully implement this process beginning June 1, 2025. Further guidance is forthcoming.
  • Specifies labeling language requirements for edible cannabis products meant for R&D use. Each product must now be labeled with the statement: “CAUTION: THIS PRODUCT IS FOR APPROVED R&D USAGE ONLY.” MCA is advising that industry implement this change on or before June 1, 2025. 

Products

Liquid edibles 

For the purposes of producing a liquid edible product, one single container is a single serving of product, and it may not contain more than 10 milligrams (mg) of tetrahydrocannabinol (THC). Liquid edibles must also comply with the requirements for other edible products in terms of production, packaging, and labeling. This includes limiting the manufacture of these products to facilities with a valid edibles permit. 

Product reservations

The following products may only be sold to qualifying patients and registered caregivers: 

  • Concentrated cannabis products with a total product weight greater than 1 gram
  • Edible cannabis products, capsules, and tinctures containing more than 10 mg THC per serving or 100 mg THC per package 

Adult use consumers may purchase: 

  • Cannabis vaporizing devices (e.g., vapes) 
  • Concentrated cannabis products with a total weight of 1 gram or less 
  • Infused flower and pre-rolls of any product weight 
  • Infused non-edible cannabis products 
  • Home cultivation products 
  • Usable cannabis products (e.g., flower, pre-rolls) 
  • Edible cannabis products, capsules, and tinctures containing up to 10 mg THC per serving or 100 mg of THC per package 

Hemp

Hemp-derived products containing more than 0.5 mg THC per serving or 2.5 mg THC per package may only be sold by licensed dispensaries if they have been manufactured, processed, and tested in accordance with MCA regulations. (Note: THC includes any THC isomers or derivatives, including delta-8 and delta-10). These products may only be displayed or offered for sale in the restricted area of a dispensary. Licensed processors may obtain hemp and hemp-derived products from registered hemp growers.  

UPDATED! Discrepancy, theft, and diversion reporting 

If a licensee identifies a discrepancy between the inventory of stock and the seed-to-sale tracking system outside or normal weight loss, they must begin an investigation of the discrepancy within 1 business day. If a discrepancy is not resolved within 30 business days, the licensee must submit a report of their investigation to MCA. Failure to report an unresolved discrepancy may be used as evidence of diversion.  

If a licensee finds evidence of theft or diversion, the licensee must report the theft or diversion to the Administration within 1 business day. 

Within 30 business days of discovering the theft, diversion, or unresolved discrepancy, the licensee must:

  • Complete an investigation; 
  • Amend its standard operating procedures, if necessary; and 
  • Send a report of the investigation to the MCA. 

Other operational considerations 

  • For packaging and labeling guidance, please refer to COMAR 14.17.18 Finished Product Packaging, as well as the General Information and Packaging and Labeling Guidance documents on the Laws and Regulations page. 
  • Visitors to any operational areas of the premises must be continuously, physically supervised at all times while on the premises. Video surveillance does not suffice for meeting supervision requirements. For growers and processors, individuals who are on the premises for the narrow purposes of package delivery, or other services that do not involve areas of the premises used for cannabis cultivation or processing are exempted from this requirement. 

Processor FAQs

The MCA has announced the names of 15 Pre-approved Processors, however, no actual final licenses to process medical cannabis have been issued. ​The pre-approved entities are current working through Stage Two of the licensing process, which includes extensive background investigations and regulatory requirements. The MCA will vote for licensure in a public meeting once compliance with the regulatory requirements is complete.

Be Informed. Be Responsible. BeCannabisSmart.

Get regulatory updates, compliance reminders, and cannabis industry news from the Maryland Cannabis Administration — delivered straight to your inbox.

Learn more and subscribe